Kyle Lewellen
Appearances
- DateMay 9, 2023Pancreatic ductal adenocarcinoma (PDAC) exists in several morphological subtypes differing in prognostic significance. However, to date, a clinico-morphological correlation of these subtypes in the context of neoadjuvant therapy (NAT) has not been performed…
Presenter
Speakers
Indiana University School of MedicineIndiana University - DateMay 6, 2023Management of patients with margin negative, T1-T3, N0 (stage IB–IIIA), resected gallbladder cancer (GBC) remains poorly defined. Current guidelines consider observation, chemotherapy (CT), and chemoradiation (CRT) as options…
Presenter
Speakers
Stanford UniversityIndiana University - DateMay 6, 2023Minimally invasive resection for perihilar cholangiocarcinoma is an emerging technique in HPB surgery which requires both liver resection and biliary reconstruction. Description of this method is very limited…
Presenter
Speakers
- DateMay 20, 2024Patients with chronic pancreatitis (CP) predominantly involving the pancreatic body/tail benefit from distal pancreatectomy (DP), with most experiencing long-term improvements in symptoms after recovery from surgery…
Presenter
Speakers
Indiana University School of MedicineIndiana University - DateMay 21, 2024Splenectomy carries risk of infectious complications. Splenic preservation (SP) avoids these immunologic consequences but is not common surgical practice. When permissible by clinical status and pathology, SP may be acceptable in select patients…
Presenter
Speakers